Home » Noven Announces Dismissal of Securities Litigation
Noven Announces Dismissal of Securities Litigation
March 18, 2005
Noven Pharmaceuticals announced that the United States District Court for the Southern District of Florida has issued an order dismissing without prejudice a lawsuit filed against Noven and certain individual defendants styled In re Noven Pharmaceuticals Securities Litigation. The notice of voluntary dismissal (attached to the order of dismissal) indicates that the lead plaintiffs and their counsel, after investigation into the allegations made in their complaint, concluded that the complaint should be voluntarily dismissed. Noven agreed to the dismissal, with each party bearing its own costs.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct